Skip to main content

Summit Financial, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1765536 PARSIPPANY, NJ

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$10,659,416
-$2,062,874 QoQ
Shares Held
17,095
+3.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#287
of 1,328 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Summit Financial, LLC holds $38,785,020 across 19 Biotechnology names. REGN ranks #2 (27.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
17,095 $10,659,416

All Filings in REGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,659,416 17,095
2026-03-31 $12,722,290 16,466
2025-12-31 $9,867,586 12,784
2025-09-30 $7,164,444 12,742
2025-06-30 $4,625,250 8,810
2025-03-31 $6,720,301 10,596
2024-12-31 $7,502,259 10,532
2024-09-30 $13,436,949 12,782
2024-06-30 $8,591,119 8,174
2024-03-31 $7,017,514 7,291
2023-12-31 $7,033,346 8,008
2023-09-30 $5,232,379 6,358
2023-06-30 $4,914,813 6,840